A Phase 1 Trial of DFMO as a Single Agent and in Combination with Etoposide in Patients with Refractory or Recurrent Neuroblastoma

Saulnier Sholler G, Gerner E, Bergendahl G, LaFleur B, VanderWerff A, Ashilkaga T, Ferguson W,  Roberts W, Wada R, Eslin D, KravekaJ, Kaplan J, Mitchell D, Parikh N, Neville K, Sender L, Higgins T, Kawakita M, Hiramatsu K, Moriya S, Bachmann A.  A Phase 1 Trial of DFMO as a Single Agent and in Combination with Etoposide in Patients with Refractory or Recurrent Neuroblastoma. American Association for Cancer Research Annual Meeting April 2013. Washington, DC